Category: Pharmaceuticals
United States Pharmaceuticals
-
Glaucoma Surgery Devices
... at a CAGR of 21.0% over the analysis period 2024-2030. Traditional Surgery, one of the segments analyzed in the report, is expected to record a 20.8% CAGR and reach US$3.1 Billion by the end of ... Read More
-
Blood Transfusion Diagnostics
... at a CAGR of 4.7% over the analysis period 2024-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Hepatitis B Vaccines
... at a CAGR of 4.4% over the analysis period 2024-2030. Combination Vaccines, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.6 Billion by the end of ... Read More
-
Flavored Syrups
... CAGR of 4.4% over the analysis period 2024-2030. Fruit Flavor, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$24.1 Billion by the end of the analysis ... Read More
-
Garden Tools
... CAGR of 4.9% over the analysis period 2024-2030. Pruning Tools, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$50.8 Billion by the end of the analysis ... Read More
-
Gaucher Disease Treatment
... at a CAGR of 3.8% over the analysis period 2024-2030. Enzyme Replacement Therapy, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$1.7 Billion by the end ... Read More
-
Library Furniture
... CAGR of 8.7% over the analysis period 2024-2030. Tables, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$3.9 Billion by the end of the analysis period. ... Read More
-
Long-Term Care
... CAGR of 5.5% over the analysis period 2024-2030. Public Payer, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.1 Trillion by the end of the analysis ... Read More
-
Microgrid as a Service (MaaS)
... Billion by 2030, growing at a CAGR of 15.7% over the analysis period 2024-2030. Grid Connected MaaS, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$4.2 ... Read More
-
Gluten Free Products
... at a CAGR of 5.9% over the analysis period 2024-2030. Gluten Free Bakery Products, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.7 Billion by the ... Read More
-
Endometrial Ablation Devices
... at a CAGR of 5.6% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$628.5 Million by the end of ... Read More
-
U.S. Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule (Biologics & Biosimilars, Conventional Drugs), By Product, By Type, By Route Of Administration, By Disease, By Age Group, By Distribution Channel, And Segment Forecasts, 2025 - 2030
... an estimated value of USD 883.97 billion by 2030. This growth can be attributed to the rising prevalence of chronic diseases, increasing geriatric population, growing healthcare expenditure by government organizations, and extensive efforts to improve ... Read More
-
Cannabis in the US
... I to Schedule III, which could attract more investment and improve banking access for cannabis businesses. Euromonitor International's Cannabis in USA market report offers a comprehensive guide to the size and shape of this emerging ... Read More
-
Pharmaceutical Manufacturing
... US), as well as AstraZeneca and GlaxoSmithKline (both based in the UK), Bayer (Germany), Novartis and Roche (both based in Switzerland), and Sanofi (France). COMPETITIVE LANDSCAPE Pharmaceutical manufacturers compete to discover and commercialize ever-more effective ... Read More
-
USA Pharmaceutical Directory 2025
... Directory 2025 The Directory is one of the most comprehensive & accurate Directory of companies & executives in the USA pharmaceutical industry. This powerful Directory is your connection to key decision-makers in the pharmaceutical industry. Read More
-
European and USA Pharmaceutical Directory 2025
... USA Pharmaceutical Directory 2025 This new Directory combines both the European Pharmaceutical Directory & USA Pharmaceutical Directory. The Directory has been thoroughly researched, to bring you a guide to Europe's & America's ever-changing pharmaceutical industries. Read More
-
Iodine Market in US 2025-2029
... market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Online Vitamin & Supplement Sales in the US - Industry Market Research Report
... boost sales, as older consumers tend to spend more on vitamins and supplements than younger demographics. The COVID-19 pandemic resulted in sales of immune system supporting vitamins and supplements surging, as consumers sought to increase ... Read More
-
U.S. Smart Pills Market - 2024-2031
... the forecast period 2024-2031. Smart pills are advanced medical devices that integrate technology with pharmaceuticals to enhance healthcare delivery. They typically consist of ingestible sensors activated upon ingestion, these sensors collect various health-related data as ... Read More
-
US Glyconutritional Supplements Market - 2024-2031
... to 2031. The demand for glyconutritional supplements in US is growing, driven by the aging population. The number of Americans aged 65 and older is expected to increase from 58 million in 2022 to 82 ... Read More
-
2025 North America Cancer Diagnostics Market in the USA, Canada, Mexico - 2024 Supplier Shares and Strategies by Country, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... LeadingMarketResearch.com provides information and analysis not available from any other published source , including 2024 supplier strategies and shares by country, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides ... Read More
-
2025 US Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
U.S. E-Prescribing Market - Focused Insights 2025-2030
... announced that it is integrating e-prescribing and medication management solutions from health technology pioneer DrFirst into its CDS system. In January 2022, Oracle announced its acquisition of Cerner Corporation, a leading supplier of health information ... Read More
-
2025 Global Cancer Diagnostics Market in the USA, Europe, Japan - 2024 Supplier Shares and Strategies by Country, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... provides information and analysis not available from any other published source , including 2024 supplier strategies and shares by country, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a ... Read More
Research Assistance
